Children onychomycosis, a neglected dermatophytosis: A retrospective study of epidemiology and treatment

Mycoses. 2023 May;66(5):448-454. doi: 10.1111/myc.13571. Epub 2023 Feb 3.

Abstract

Background: Onychomycosis was an ignored disease in children, and the prevalence was still unknown worldwide.

Objectives: This study was conducted to investigate the prevalence and treatment regimens of onychomycosis in children younger than 18 years old.

Methods: We systemically reviewed all publications by searching the key terms to reveal the onychomycosis in children from 1990 to 2022.

Results: A total of 44 articles including 2,382 children with onychomycosis were enrolled in this study. The male to female ratio was 1.29:1. The youngest child was 35 days old and the average age was 9.8 years old. The duration of disease usually ranged from 7 days to 4 years. Onychomycosis in children was more prevalent in toenails compared to fingernails (77.6% vs. 18.4%), and 4% patients had both. A total of 527 children (22.12%) had concomitant tinea pedis infection, and in 267 patients (11.21%), their family members had onychomycosis or tinea pedis. The most common clinical type of onychomycosis was DLSO (67.74%) and the predominant isolates were T. rubrum (66.13%), followed by C. albicans (9.08%) and T. mentagrophytes complex (5.34%). There were 419 children (74.03%) receiving systematic treatment only, 74 patients (13.07%) receiving topical treatment only, and 73 patients (12.90%) receiving both systematic and topical treatment. Twelve patients (2.12%) had mild drug-related side effects. During the follow-up, 71.25% children were cured, 17.50% symptoms improved and 4.17% failed.

Conclusions: Onychomycosis was underestimated in children and the diagnosis of onychomycosis should be properly considered in children with nail disorders. For mild patients, topical treatment can be a good choice, and oral antifungal drugs could be added to severe individuals under monitoring.

Keywords: children; epidemiology; onychomycosis; treatment.

MeSH terms

  • Adolescent
  • Antifungal Agents
  • Candida albicans
  • Child
  • Female
  • Humans
  • Male
  • Nails / microbiology
  • Onychomycosis* / diagnosis
  • Onychomycosis* / drug therapy
  • Onychomycosis* / epidemiology
  • Retrospective Studies
  • Tinea Pedis / microbiology

Substances

  • Antifungal Agents